The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-3-(5-((2-cyanoquinolin-4-yl)(methyl)amino)-2-methoxyphenyl)-N-hydroxyacrylamide ID: ALA5183440
PubChem CID: 146469200
Max Phase: Preclinical
Molecular Formula: C21H18N4O3
Molecular Weight: 374.40
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(N(C)c2cc(C#N)nc3ccccc23)cc1/C=C/C(=O)NO
Standard InChI: InChI=1S/C21H18N4O3/c1-25(19-12-15(13-22)23-18-6-4-3-5-17(18)19)16-8-9-20(28-2)14(11-16)7-10-21(26)24-27/h3-12,27H,1-2H3,(H,24,26)/b10-7+
Standard InChI Key: QHXOKFICRLZQNX-JXMROGBWSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
-3.5719 0.6190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8574 1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1454 0.6193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1454 -0.2057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8555 -0.6175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5719 -0.2094 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.2838 1.0309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2838 1.8561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5738 2.2679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8574 1.8598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4308 1.0320 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7162 0.6193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0014 1.0318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7106 0.6198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7106 -0.2054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0002 -0.6173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7162 -0.2092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4252 -0.6181 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1399 -0.2054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4308 1.8572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8555 -1.4426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8555 -2.2679 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4252 1.0324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1399 0.6198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8544 1.0324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5692 0.6198 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8544 1.8576 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2838 1.0324 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
1 7 1 0
8 7 2 0
9 8 1 0
10 9 2 0
2 10 1 0
3 11 1 0
11 12 1 0
13 12 2 0
14 13 1 0
15 14 2 0
16 15 1 0
17 16 2 0
12 17 1 0
15 18 1 0
18 19 1 0
11 20 1 0
5 21 1 0
21 22 3 0
14 23 1 0
23 24 2 0
24 25 1 0
25 26 1 0
25 27 2 0
26 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 374.40Molecular Weight (Monoisotopic): 374.1379AlogP: 3.40#Rotatable Bonds: 5Polar Surface Area: 98.48Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.55CX Basic pKa: 3.21CX LogP: 3.23CX LogD: 3.23Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.40Np Likeness Score: -0.67
References 1. Hauguel C, Ducellier S, Provot O, Ibrahim N, Lamaa D, Balcerowiak C, Letribot B, Nascimento M, Blanchard V, Askenatzis L, Levaique H, Bignon J, Baschieri F, Bauvais C, Bollot G, Renko D, Deroussent A, Prost B, Laisne MC, Michallet S, Lafanechère L, Papot S, Montagnac G, Tran C, Alami M, Apcher S, Hamze A.. (2022) Design, synthesis and biological evaluation of quinoline-2-carbonitrile-based hydroxamic acids as dual tubulin polymerization and histone deacetylases inhibitors., 240 [PMID:35797900 ] [10.1016/j.ejmech.2022.114573 ]